NEW ORAL ANTICOAGULANT DRUGS IN ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROME

NEW ORAL ANTICOAGULANT DRUGS IN ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROME

After an acute coronary syndrome, patients remain at risk of recurrent ischemic events despite the use of antiplatelet therapy. In order to reduce the risk of recurrent ischemia in the treatment of patients with acute coronary syndromes, standard oral anticoagulants, such as vitamin K antagonists,...

Full description

Bibliographic Details
Main Authors: Aleksandra Novaković, Tatjana Divac, Ivan Stojanović, Predrag Milojević, Dragoslav Nenezić
Format: Article
Language:English
Published: University in Nis, Faculty of Medicine 2013-09-01
Series:Acta Medica Medianae
Subjects:
new oral anticoagulants
acute coronary syndrome
atrial fibrillation
thrombin
factor Xa
Online Access:http://publisher.medfak.ni.ac.rs/2013-html/3-broj/6%20-%20Aleksandra%20Novakovic-New%20Oral-.pdf

Internet

http://publisher.medfak.ni.ac.rs/2013-html/3-broj/6%20-%20Aleksandra%20Novakovic-New%20Oral-.pdf

Similar Items